首页> 外文会议>World congress on medical physics and biomedical engineering;International congress of the IUPESM >In-Phantom Peripheral Organ Doses from Prostate Irradiation Using 18 MV External Beam Radiotherapy Measured with 6LiF:Mg,Cu,P 7LiF:Mg,Cu,P Glass-Rod TLDs
【24h】

In-Phantom Peripheral Organ Doses from Prostate Irradiation Using 18 MV External Beam Radiotherapy Measured with 6LiF:Mg,Cu,P 7LiF:Mg,Cu,P Glass-Rod TLDs

机译:使用18 MV外部束放射疗法通过6LiF:Mg,Cu,P和7LiF:Mg,Cu,P玻璃棒TLD测量的前列腺癌辐射产生的幻影周围器官剂量

获取原文

摘要

A radiation dosimetry technique based on pairs of LiF:Mg,Cu,P and ~7LiF:Mg,Cu,P glass-rod TLDs was developed for measuring peripheral photon and neutron doses in the humanoid Rando phantom as a result of prostate irradiation using the 18 MV three-dimensional conformal radiotherapy (3D-CRT). The peripheral doses for different organs were estimated from TLD measurements and the risks of radiation-induced second malignancy were estimated using the competitive risk and linear no-threshold models. It was observed that following 80 Gy prostate irradiation using 18 MV 3D-CRT technique, both photons and neutrons doses ranged from approximately 97 mSv (in thyroid) to 807 mSv (in colon). Using the competitive risk model, the estimated risk of second malignancy was found to be ranging from 0.5% (for lungs) to 3.3% (for colon). Due to low doses (<2 Gy) exposure, estimation of the risk of second malignancy using the linear no-threshold model resulted in similar values as obtained with the competitive risk model. In conclusion, 6LiF:Mg,Cu,P and 7LiF:Mg,Cu,P glass-rod TLDs can be used in pairs to enable determination of photon and neutron doses simultaneously in a Rando phantom and to evaluate the impact of prostate cancer irradiation with high-energy (18 MV) 3D-CRT technique on the risk of second malignancy in various organs.
机译:研发了一种基于LiF:Mg,Cu,P和〜7LiF:Mg,Cu,P玻璃棒TLD对的辐射剂量测定技术,用于测量人形Rando体模中由于前列腺照射而产生的周围光子和中子剂量。 18 MV三维共形放射治疗(3D-CRT)。根据TLD测量值估算不同器官的外周剂量,并使用竞争风险和线性无阈值模型估算辐射诱发的第二恶性肿瘤的风险。观察到在使用18 MV 3D-CRT技术进行80 Gy前列腺照射后,光子和中子的剂量范围从大约97 mSv(在甲状腺中)到807 mSv(在结肠中)。使用竞争风险模型,发现第二恶性肿瘤的估计风险范围为0.5%(对于肺)至3.3%(对于结肠)。由于低剂量(<2 Gy)暴露,使用线性无阈值模型估算第二次恶性肿瘤的风险可得到与竞争风险模型相似的值。总之,可以成对使用6LiF:Mg,Cu,P和7LiF:Mg,Cu,P玻璃棒TLD,以同时确定Rando体模中的光子和中子剂量,并评估用Pd照射前列腺癌的影响。高能量(18 MV)3D-CRT技术对各种器官发生第二次恶性肿瘤的风险。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号